Thioredoxin and Thioredoxin Reductase As Redox-Sensitive Molecular Targets for Cancer Therapy

E-ISSN： 1873-4286|13|33|3368-3377

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.33, 2007-11, pp. : 3368-3377

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Novel Mercaptopyruvate Sulfurtransferase Thioredoxin-Dependent Redox-Sensing Molecular Switch: A Mechanism for the Maintenance of Cellular Redox Equilibrium

Mini Reviews in Medicinal Chemistry, Vol. 8, Iss. 6, 2008-06 ,pp. : 585-589

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Thioredoxin Reductase: Anticancer Agents and Chemopreventive Compounds

Medicinal Chemistry, Vol. 6, Iss. 5, 2010-09 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents

Current Drug Targets, Vol. 13, Iss. 11, 2012-10 ,pp. : 1432-1444

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Targets for Epigenetic Therapy of Cancer

Current Pharmaceutical Biotechnology, Vol. 10, Iss. 2, 2009-02 ,pp. : 161-165

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular targets for cell cycle inhibition and cancer therapy

By Lee Mong-Hong Yang Heng-Yin

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 3, 2003-03 ,pp. : 329-346

Informa Healthcare

Access to resources Recommend Favorite